2016 American Transplant Congress Archives - Page 6 of 180

3:06pm-3:18pm: Investigating Geographic Variation in the Number of Deceased Donor Transplants Performed in the U.S.

R. Carrico, D. Stewart, R. Ehrensberger, B. Shepard, D. Klassen.

Concurrent Session: Disparities in Transplant Access and Outcomes • Room 312

3:06pm-3:18pm: Investigating Posttransplant Allo-Donor Specific CD57⁺ Cells in Patients with Alemtuzumab Induction and Belatacept-Based Regimen.

H. Xu, F. Feng, A. Kirk.

Concurrent Session: Kidney Immunosuppression: Novel Agents • Veterans Auditorium

3:06pm-3:18pm: Machine Perfusion (MP) at 21[deg]C Simulates Hibernation Metabolic Pathways in a Non-Hibernator Mammal.

B. Banan, S. Dobrowolski, G. Michalopoulos, P. Fontes.

Concurrent Session: Ischemic Injury and Organ Preservation: Animal Models • Room 313

3:06pm-3:18pm: Offering HCV-Positive Kidneys to HCV-Negative Patients on the Kidney Transplant Waitlist Is Lifesaving: Results of a Markov Model.

D. Goldberg, P. Reese, V. Potluri, F. Scott.

Concurrent Session: Living Donation and Transplant: Operational and Economic Factors • Room 311

3:06pm-3:18pm: Recurrence of FSGS Post Kidney Transplantation: Salvage Therapy with ACTHAR® Gel.

P. Vaitla, D. Daswatta, A. Guasch.

Concurrent Session: It's Just Not the Donor: Impact of Recipient Factors on Outcomes • Ballroom A

3:06pm-3:18pm: Sphingosine 1-Phosphate (S1P) Receptors Differentially Regulate Murine and Human CD4 T Cell Migration Across Lymphatic Endothelium.

Y. Xiong,¹ C. Brinkman,¹ K. Hippen,² B. Blazar,² J. Bromberg.¹

Concurrent Session: T Cell Biology and Alloimmunity: Animal Models • Room 310

3:06pm-3:18pm: Targeting the Constitutively Active PI3K/Akt/mTOR Signaling Pathway in Epstein-Barr Virus B Cell Lymphomas.

A. Sang, G. Ivison, C. Esquivel, S. Krams, O. Martinez.

Concurrent Session: PTLD and Malignancies • Room 206

3:06pm-3:18pm: Vascularized Composite Allograft Tolerance with Transient High-Dose Tacrolimus Across a Full MHC Mismatch in a Large Animal Model.

H. Wang, E. Swanson, H.-T. Cheng, J. Walch, J. Alonso-Esclante, K. Kolegraff, J. Lopez, G. Furtmuller, B. Oh, A. Quan, J. Budihardjo, S. AlFadil, S. Mulla, P. Akre, J. Sacks, S. Bonawitz, G. Raimondi, J. Shores, D. Cooney, W. Lee, G. Brandacher.

Concurrent Session: Clinical Vascularized Composite Allotransplantation • Room 102

3:06pm-3:18pm: What Are the Charges and Costs of Transplanting High MELD Patients?

K. Bortecen, B. Gelb, A. Winnick, G. Morgan, L. Teperman.

Concurrent Session: Liver: MELD, Allocation and Donor Issues (DCD/ECD) 1 • Room 304

3:18pm-3:30pm: “Day 2 Discharge” After Kidney Transplantation: Complications, Health Care Utilization, and Long-Term Clinical Outcomes.

A. Mathur, N. Katariya, A. Welu, J. Chang, R. Heilman, A. Singer, H. Khamash, H. Chakkera, W. Hewitt, D. Haakinson, M. Maningo-Salinas, E. Oakley, A. Moss, K. Reddy.

Concurrent Session: Kidney: Length of Stay/Readmission • Room 302